Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Weekend | Pharma | 10.1% | 37th pct | 110 |
| Helios Pharma | Pharma | -24.5% | 2nd pct | 110 |
| New Medi | Pharma | — | no FY data | 110 |
| Medi-Hels | Pharma | — | no FY data | 110 |
| Deilait Kompani | Pharma | — | no FY data | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 2 of 5 peers filed FY2024. Switch to FY2021 (5 of 5).
| Line item | Helios Pharma | Weekend | New Medi | Medi-Hels | Deilait Kompani |
|---|---|---|---|---|---|
| Total Current Assets | 12,305 | 7,291 | — | — | — |
| Total Non-Current Assets | 7 | 4,984 | — | — | — |
| TOTAL ASSETS | 12,311 | 12,275 | — | — | — |
| Total Current Liabilities | 0 | 4,873 | — | — | — |
| Total Non-Current Liabilities | 92 | -692 | — | — | — |
| TOTAL LIABILITIES | 92 | 4,181 | — | — | — |
| Total Equity | 12,219 | 8,094 | — | — | — |
| Balance Check (Assets - L&E) | 0 | 0 | — | — | — |
| Total Debt | 0 | 3,750 | — | — | — |
| Cash & Equivalents | 853 | 2,418 | — | — | — |
| Net Debt | -853 | 1,332 | — | — | — |
Not every picked company reports every selected year — FY2024: 3 of 5 companies have no filing. Those cells are left blank (no filing), not zero.